Cessation of marketing of several insulins

I leave this info that have happened to me:

Link HTI79IU_AEM_FFRC_GGZXAMUR80PCJ0PWQ#

I have never had problems with Novorapid Flexpen ... do they say since 2023?I don't know.

ruthbia said:
I have never had problems with Novorapid flexpen ... do they say since 2023?I don't know.

At work today has also reached me.Then I will read it.

meginer said:

ruthbia said:
I have never had problems with Novorapid flexpen ... do they say since 2023?I don't know.

At work today has also reached me.Then I will read it.

Pass it please, if it is something important

Basically it is the same as Ruthbia has put.Above all Actrapid Innolet (which is barely used), Novorapid Flexpen, Fiasp, Levemir Innolet.
I imagine that they will solve it and that the lack of stock will not be in all pharmacies at the same time ...
A priori does not affect me at the moment PQ use Humalog and Tresiba but you never know.A roll to have to be aware of this.

This is more a form of laboratory pressure to raise prices.
If I have novo, I have an insulin Humalog prescribed, so they are going to lose more.

If we fail, then nothing to the header and that it prescribes another.
We will have to try whatever it is, although we have never used it, never put on is not the solution.